Fintech PR
Hong Kong’s first listed social responsibility index release “Hong Kong Main Board Listed Companies Social Responsibility Index”
On October 2, Rising Glory Financial limited company, with Sodata Analytics Foundation Association and LBS Communications Consulting Limited, jointly released the Hong Kong Main Board Listed Companies Social Responsibility Index Series, which establish a standardized and intuitive assessment method to quantitatively evaluate the company performance in social responsibility and governance.
With a number of social issues such as global warming, resource depletion and environmental pollution continuously emerging, more and more investors are aware of the impact of these non-financial factors on the operating stability and stakeholder values of the companies. Hence, Environment, Social Responsibility, Corporate Governance (“ESG”) factors have received extensive attention from the public. ESG is a standard used by investors to screen social-responsible investment targets and make investment decisions. The environmental factor examines the environmental protection concerns of companies; the social factor studies the ability of companies managing their relationship with the employees and communities around; corporate governance involves executive compensation, the corruption and litigation issues.
At present, international index developers have launched a number of ESG indices and derivative ETF investment products. The MSCI KLD 400 Social Index was created in May 1990 and is the world’s first ESG index. The most influential indices are the MSCI ESG Series Index (Global/US/Emerging Markets), the FTSE4Good Series Index, and The Dow Jones Sustainability Series Index. The ESG-themed fund is also part of the relevant investment products issued by the international mainstream fund companies. Among them, BlackRock’s MSCI US ESG ETF fund and Vanguard’s FTSE Social Fund are among the most famous.
Traditional ESG evaluation requires a lot of effort to study and evaluate environmental governance and business management of different companies from different industries, and it is difficult to give a standardized evaluation through a uniform method. In addition, many aspects of ESG, such as environmental indicators, employee management indicators, etc., are mandatory indicators. Only the social responsibility is a voluntary one, which we see as an alternative useful indicator to reflect corporate social responsibility. For example, many companies will voluntarily invest a lot of human and financial resources into environment, education, health care and other charitable causes.
The Hong Kong Main Board Listed Companies Social Responsibility Index (Sodata Index) selects 100 stocks from the underlying stocks in Hong Kong’s main board with higher social score ratings as index components. The social score rating consists of RGF self-developed evaluation factors such as the amount of donations, the growth rate of donations and the coefficient of sustainable donations which is the measurement of the implementation of charitable activities by enterprises on a continuing basis. The coefficient is based on the performance of the enterprise’s continuous contributions on an exponential weighted average basis, thus reflecting better scoring for enterprises with sustainable contributions. The Hong Kong Blue Chip Listed Companies Social Responsibility Index (Blue Chip Sodata Index) selects the constituent stocks of the Hong Kong Hang Seng Index as index components and adjusts the market capitalization weight according to the social score ratings.
As the first index based on the social score rating of listed companies in Hong Kong, the Sodata index started on June 2, 2015 as the base date, with a base point of 1,000 points. Comparing the performance of the Sodata Index, since June 2, 2015, the Sodata Index has increased by 7.08%, while the Hang Seng Index has fallen by 5.45%. Since January 2, 2019, the Sodata Index has fallen by 2.94%, and the Hang Seng Index has risen during the same period 3.83%. Comparing the performance of the Blue Chip Sodata Index, since June 2, 2015, the Blue Chip Sodata Index has increased by 18.10%. Since January 2, 2019, the Blue Chip Sodata Index has increased by 2.48%.
Michael Yip, one of the founders of the Sodata Analytics Foundation Association, said: “ESG is the new darling of the current investment community. In 2018, almost a quarter of global funds has adopted ESG standards for investment decisions. As ESG and related regulations become more sophisticated, ESG Investment has a huge positive effect on the market, companies, investors and government regulators. According to the Hong Kong Sodata Analytics Foundation research, the top 100 corporate social responsibility (CSR) in the past three years, has demonstrated a relatively high return on alpha and lower volatility. It is believed that the Sodata Index would be a better tool to track the stock movements of companies with higher social responsibility in the Hong Kong main board market.”
Joanne Chan, Managing Director of LBS Communications Consulting Limited, said: “The Principles for Responsible Investment (PRI) supported by United Nations reflect the relationship between ESG and the capital markets, and provides a framework for global investors to make a long term and sustainable investment decision. It also facilitates the development of a stable capital market. PRI is in line with the long-term interests of investors and global capital markets. It is also in line with the long-term interests of environmental and societal causes, a redefinition of current investment behavior. The ESG investment concept is gradually gaining widespread recognition from global asset owners, investment institutions, regulators and other investors. According to UN PRI data, as of August 2018, more than 2,000 organizations around the world signed up with assets of more than 80 trillion US dollars. PRI has had a profound impact on the long-term and sustainable development of capital markets. ”
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News4 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News4 days ago
IHG Hotels & Resorts and NOVUM Hospitality sign agreement that doubles IHG’s hotel presence in Germany, launches Holiday Inn – the niu collaboration, and debuts Garner and Candlewood Suites brands
-
Latest News4 days ago
Fiat infrastructure Leader Banxa join forces with Venom foundation in offering Venom-supported tokens access to its global Fiat rails